• -
  • English
  • Japanese
  • Korean
市場調查報告書
商品編碼
1008063

體外受精 (IVF) 市場：2020-2026

In-Vitro Fertilization (IVF) Market 2020-2026
出版日期: | 出版商: Orion Market Research Pvt Ltd | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

在預測期內，全球體外受精 (IVF) 市場預計將以約 9.6% 的高複合年增長率增長。試管嬰兒在醫療保健領域對不孕症的治療發揮著重要作用。這是一系列程序，用於預防遺傳問題和治療不孕症，同時支持受孕。體外受精包括在培養皿中混合雌性卵子和雄性精子並將它們移植到子宮中。體外受精有五個程序，包括藥物、卵子收集、受精、胚胎培養和胚胎移植。

體外受精的完整週期大約需要 3 週。這是為 40 歲以上有不孕症的女性推薦的主要治療方法。 IVF 可以通過兩種受精技術進行：授精和卵胞漿內單精子注射 (ICSI)。用於這種治療的設備包括專用顯微鏡、孵化器、超聲設備和試管嬰兒一次性用品。它可以為有排卵障礙、不明原因不孕症、子宮內膜異位症和子宮肌瘤等問題的人和他們的伴侶進行。

不孕症患病率的上升導致對 IVF 程序的需求增加，這推動了市場增長。此外，輔助生殖技術的增長趨勢和政府為改善生育治療的可及性所做的有利可圖的努力正在進一步推動市場增長。然而，有幾個因素限制了市場增長，例如與治療相關的高成本和與 IVF 治療相關的風險，如多胞胎、流產、卵子收集程序的併發症、早產、低體重和異位妊娠。有。然而，生育診所的擴張為市場增長提供了機會。

本報告探討了體外受精 (IVF) 市場，並按程序類型、產品、最終用戶、地區和進入市場的公司概況介紹了市場概況以及趨勢。

目錄

第 1 章報告概述

第 2 章市場概覽和洞察

  • 調查範圍
  • 分析師洞察和當前市場趨勢
  • 規則和規則

第 3 章競爭形勢

  • 公司股票分析
  • 主要戰略分析
  • 主要公司分析
    • Cooper Surgical, Inc.
    • Vitrolife AB
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Fujifilm Holdings Corp. (Irvine Scientific)

第 4 章市場決定因素

  • 動力
  • 抑制因素
  • 市場機會

第 5 章市場細分

  • 全球體外受精市場，按程序類型
    • 冷凍供體
    • 冷凍非捐贈者
    • 新鮮捐贈者
    • 新鮮非供體
  • 按產品分類的全球體外受精市場
    • 試劑
    • 設備
    • 軟件
  • 全球體外受精市場，按最終用戶
    • 醫院和調查
    • 不孕症診所和外科中心
    • 其他

第 6 章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 其他領域

第 7 章公司簡介

  • Cook Medical Inc.
  • CRITEX GmbH
  • Esco Micro Pte Ltd.
  • Genea Ltd.
  • Hamilton Thorne, Inc.
  • Illumina, Inc
  • Inventia Genetic Technologies Pty Ltd.
  • INVO Bioscience Inc.
  • IVFtechApS
  • Kitazato Corp.
  • Nidacon International AB
  • Nikon Corp.
  • Pantec BioSolutions AG
  • Rocket Medical plc
  • Trivector Biomed LLP
目錄
Product Code: OMR2023356

Global In-Vitro Fertilization (IVF) Market By Procedure Type (Frozen Donor, Frozen Non-Donor, Fresh Donor, Fresh Non-Donor, Embryo Banking), By Product (Reagents, Equipment, and Software), By End-User (Hospitals and Research Laboratories, Fertility Clinics and Surgical Centers, and Others), Forecast Period 2021-2027

The global in-vitro fertilization (IVF) market is growing at a significant CAGR of nearly 9.6% during the forecast period. IVF plays a vital role in the health care sector for the treatment of infertility. It is a series of procedures that are used to prevent genetic problems and treat infertility while supporting the conception of a child. Under the IVF procedure, a woman's egg and a man's sperm are combined in a laboratory dish and then it is transferred to a uterus. There is five procedure involved in the IVF procedure such as medication, harvest the eggs, fertilization, embryo culture, and embryo transfer.

A full cycle of IVF can take about three weeks. It is a primary treatment that is suggested for women with infertility problem above the age of 40. IVF can be done by two fertilization techniques that are insemination and intracytoplasmic sperm injection (ICSI). The devices that are used for this treatment are the special microscope, incubators, ultrasound machines, IVF disposables and other such devices. It can be done if people and their partner have problems such as ovulation disorders, unexplained infertility, endometriosis, uterine fibroids, among other problems.

An increasing prevalence of infertility is leading to increasing demand for IVF procedure and thereby is driving the market growth. Additionally, the increasing trends of assisted reproductive technology and favorable government initiatives to increase the accessibility of infertility treatment are further driving the growth of the market. However, some factors are restraining the market growth include high cost associated with the treatment, and the risk associated with the IVF treatment such as multiple births, miscarriage, egg-retrieval procedure complications, premature delivery and low birth weight, and ectopic pregnancy, among others. However, the expansion of infertility clinics is offering an opportunity for market growth.

Segmental Outlook

The market is segmented based on procedure type, product, and end-user. Based on procedure type, the market is segmented into the frozen donor, frozen non-donor, fresh donor, and fresh non-donor. Based on the product, the market is segmented into reagents, equipment, and software. Based on the end-user, the market is segmented into hospitals and research laboratories, fertility clinics and surgical centers, and others.

Global IVF Market Share by End User, 2020 (%)

Source: OMR Global

Fertility Clinics and Surgical Centers to Witness Fastest Growth During the Forecast Period

Expansion of fertility clinics is one of the major factors resulting in a potential share of fertility clinics and surgical centers. Rising incidences of infertility have resulted in the expansion of fertility clinics and surgical centers. For instance, in November 2020, Nova IVF Fertility launched a new state-of-the-art IVF center in Kolkata, India. The center is led by highly qualified IVF specialists, trained embryologists, Global Standards and Protocols, the latest embryology lab, and a comprehensive range of fertility solutions. Other major fertility clinics focusing on the expansion of their centers globally include IntegraMed America, Inc. and Western Fertility Institute.

Regional Outlook

The market is analyzed based on geographical regions such as North America, Europe, Asia Pacific, and the Rest of the World. Europe is one of the major markets for IVF treatment globally. Rising incidences of infertility and rising medical tourism are some factors accelerating the demand for IVF treatment across Europe. As per the Fertility Europe VZW data published in October 2020, over 25 million citizens are affected by infertility across Europe. Additionally, significant focus on advanced technologies and the availability of IVF treatment at low cost are some of the major causes that are surging the market growth in Europe.

Global IVF Market Growth by Region, 2021-2027

Source: OMR Global

Asia-Pacific is Expected to Witness Potential Share in the Market During the Forecast Period

Asia-Pacific is estimated to be the fastest-growing market during the forecast period. Several factors are driving the growth of the market such as increasing ovulation disorder in women, increasing trends of assisted reproduction technology, and increasing rate of infertility. Additionally, government initiatives for fertility treatment are expected to offer an opportunity for market growth. For instance, in November 2017, the Telangana government (Indian state) declared that it will start fertility centers at government hospitals to increase the accessibility of infertility treatment among couples. This, in turn, is expected to further drive the market growth in the region.

Market Players Outlook

Key players operating in the market include CooperSurgical, Inc., Vitrolife AB, Thermo Fisher Scientific Inc., Merck KGaA, and Fujifilm Holdings Corp. To survive in the market, these market players adopt different marketing strategies such as merger and acquisitions, product launches, and geographical expansion to expand their market share. For instance, in February 2021, TMRW Life Sciences declared that it has launched the world's first automated cryo specimen management solution for embryos and eggs used in IVF. TMRW's proprietary platform has been installed in multiple premier fertility clinics in the US, launching the modern era of integrated, software-enabled management of the millions of eggs and embryos central to modern IVF. The company is expanding globally and declared that it will be in UK-based fertility clinics in the summer of 2021.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global IVF market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market-entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules and Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Cooper Surgical, Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Vitrolife AB
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Thermo Fisher Scientific Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Merck KGaA
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Fujifilm Holdings Corp. (Irvine Scientific)
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global IVF Market by Procedure Type
    • 5.1.1. Frozen Donor
    • 5.1.2. Frozen Non-Donor
    • 5.1.3. Fresh Donor
    • 5.1.4. Fresh Non-Donor
  • 5.2. Global IVF Market by Product
    • 5.2.1. Reagents
    • 5.2.2. Equipment
    • 5.2.3. Software
  • 5.3. Global IVF Market by End-User
    • 5.3.1. Hospitals and Research Laboratories
    • 5.3.2. Fertility Clinicsand Surgical Centers
    • 5.3.3. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Cook Medical Inc.
  • 7.2. CRITEX GmbH
  • 7.3. Esco Micro Pte Ltd.
  • 7.4. Genea Ltd.
  • 7.5. Hamilton Thorne, Inc.
  • 7.6. Illumina, Inc
  • 7.7. Inventia Genetic Technologies Pty Ltd.
  • 7.8. INVO Bioscience Inc.
  • 7.9. IVFtechApS
  • 7.10. Kitazato Corp.
  • 7.11. Nidacon International AB
  • 7.12. Nikon Corp.
  • 7.13. Pantec BioSolutions AG
  • 7.14. Rocket Medical plc
  • 7.15. Trivector Biomed LLP

LIST OF TABLES

  • 1. GLOBAL IVF MARKETRESEARCH AND ANALYSIS BY PROCEDURE TYPE, 2020-2027($ MILLION)
  • 2. GLOBAL FROZEN DONORIVF MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 3. GLOBAL FROZEN NON-DONORIVF MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 4. GLOBAL FRESH DONOR MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 5. GLOBAL FRESH NON-DONOR MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 6. GLOBAL IVFMARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027($ MILLION)
  • 7. GLOBAL IVF REAGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 8. GLOBAL IVF EQUIPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 9. GLOBAL IVF SOFTWAREMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027($ MILLION)
  • 10. GLOBAL IVF MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027($ MILLION)
  • 11. GLOBAL IVF IN HOSPITALS AND LABIRATORIESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL IVF IN FERTILITY CLINICS AND SURGICAL CENTERSMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL IVF IN OTHER END-USERSMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL IVF MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 15. NORTH AMERICAN IVF MARKET RESEARCH AND ANALYSISBY COUNTRY, 2020-2027($ MILLION)
  • 16. NORTH AMERICAN IVF MARKET RESEARCH AND ANALYSIS BY PROCEDURE TYPE, 2020-2027($ MILLION)
  • 17. NORTH AMERICAN IVF MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027($ MILLION)
  • 18. NORTH AMERICAN IVF MARKET RESEARCH AND ANALYSIS BY END-USER,2020-2027($ MILLION)
  • 19. EUROPEAN IVF MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 20. EUROPEANIVF MARKET RESEARCH AND ANALYSIS BY PROCEDURE TYPE, 2020-2027 ($ MILLION)
  • 21. EUROPEANIVF MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 22. EUROPEANIVF MARKET RESEARCH AND ANALYSIS BY END-USER,2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC IVFMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
  • 24. ASIA-PACIFIC IVFMARKET RESEARCH AND ANALYSIS BY PROCEDURE TYPE, 2020-2027($ MILLION)
  • 25. ASIA-PACIFIC IVF MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027($ MILLION)
  • 26. ASIA-PACIFIC IVF MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 27. REST OF THE WORLD IVFMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027($ MILLION)
  • 28. REST OF THE WORLD IVFMARKET RESEARCH AND ANALYSIS BY PROCEDURETYPE, 2020-2027($ MILLION)
  • 29. REST OF THE WORLD IVF MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 30. REST OF THE WORLD IVF MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL IVF MARKET SHARE BY PROCEDURE TYPE, 2020 VS 2027 (%)
  • 2. GLOBAL IVF MARKET SHARE BY PRODUCT, 2020 VS 2027 (%)
  • 3. GLOBAL IVF MARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 4. GLOBAL IVF MARKETSHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 5. GLOBAL FROZEN DONORIVF MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 6. GLOBAL FROZEN NON-DONORIVF MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 7. GLOBAL FRESH DONOR IVF MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 8. GLOBAL FRESH NON-DONORIVF MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 9. GLOBAL IVF REAGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL IVF EQUIPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL IVF SOFTWAREMARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL IVF IN HOSPITALS AND RESEARCH LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL IVF IN FERTILITY CLINICSAND SURGICAL CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 14. GLOBAL IVF IN OTHER END-USERSMARKET RESEARCH AND ANALYSIS BY REGION, 2020 VS 2027 (%)
  • 15. US IVFMARKET SIZE, 2020-2027($ MILLION)
  • 16. CANADA IVF MARKETSIZE, 2020-2027($ MILLION)
  • 17. UK IVFMARKET SIZE, 2020-2027($ MILLION)
  • 18. FRANCE IVF MARKET SIZE, 2020-2027($ MILLION)
  • 19. GERMANY IVF MARKET SIZE, 2020-2027($ MILLION)
  • 20. ITALY IVF MARKET SIZE, 2020-2027($ MILLION)
  • 21. SPAIN IVF MARKET SIZE, 2020-2027($ MILLION)
  • 22. REST OF EUROPE IVF MARKETSIZE, 2020-2027($ MILLION)
  • 23. INDIA IVF MARKET SIZE, 2020-2027($ MILLION)
  • 24. CHINA IVFMARKETSIZE, 2020-2027($ MILLION)
  • 25. JAPAN IVF MARKET SIZE, 2020-2027($ MILLION)
  • 26. REST OF ASIA-PACIFIC IVF MARKET SIZE, 2020-2027($ MILLION)
  • 27. REST OF THE WORLD IVF MARKET SIZE, 2020-2027($ MILLION)